Conversion surgery for stage IV gastric cancer after third-line immunotherapy: a case report
Sevindzh F. Evdokimova, Anna L. Kornietskaya, Larisa V. Bolotina, Iliya V. Kolobayev, Alexander A. Fedenko, Andrey D. Kaprin · 2024
Read Conversion surgery for stage IV gastric cancer after third-line immunotherapy: a case report by Sevindzh F. Evdokimova, Anna L. Kornietskaya, Larisa V. Bolotina, Iliya V. Kolobayev, Alexander A. Fedenko, Andrey D. Kaprin (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11659121.txt.
Description
Sevindzh Evdokimova and co-workers report conversion surgery for stage IV gastric cancer after immune therapy, in a 2024 case paper. Survival at five years for this stage is under ten percent, even with modern drug treatment. Conversion surgery removes the tumor after a strong drug response has shrunk the disease. Their patient received the immune drug pembrolizumab as a third-line treatment, then underwent surgery. No recurrence appeared during twenty-two months of follow-up after the operation.
Catalog record
| CREATOR | Sevindzh F. Evdokimova, Anna L. Kornietskaya, Larisa V. Bolotina, Iliya V. Kolobayev, Alexander A. Fedenko, Andrey D. Kaprin |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 13 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |